These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 30544177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Somatic mutations in intracranial arteriovenous malformations.
    Goss JA, Huang AY, Smith E, Konczyk DJ, Smits PJ, Sudduth CL, Stapleton C, Patel A, Alexandrescu S, Warman ML, Greene AK.
    PLoS One; 2019; 14(12):e0226852. PubMed ID: 31891627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
    Oka M, Kushamae M, Aoki T, Yamaguchi T, Kitazato K, Abekura Y, Kawamata T, Mizutani T, Miyamoto S, Takagi Y.
    World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
    [Abstract] [Full Text] [Related]

  • 8. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K, Tsurutani J, Yamanaka T, Yoneshige A, Ito A, Togashi Y, De Velasco MA, Terashima M, Fujita Y, Tomida S, Tamura T, Nakagawa K, Nishio K.
    PLoS One; 2015 Jun; 10(5):e0121891. PubMed ID: 25954997
    [Abstract] [Full Text] [Related]

  • 9. Arteriovenous malformation phenotype resembling congenital hemangioma contains KRAS mutations.
    Sudduth CL, McGuire AM, Smits PJ, Konczyk DJ, Al-Ibraheemi A, Fishman SJ, Greene AK.
    Clin Genet; 2020 Dec; 98(6):595-597. PubMed ID: 32799314
    [Abstract] [Full Text] [Related]

  • 10. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
    Nikolaev SI, Fish JE, Radovanovic I.
    N Engl J Med; 2018 Apr 19; 378(16):1561-1562. PubMed ID: 29669234
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer.
    Nicoś M, Krawczyk P, Jarosz B, Sawicki M, Szumiłło J, Trojanowski T, Milanowski J.
    Clin Exp Med; 2016 May 19; 16(2):169-76. PubMed ID: 25902737
    [Abstract] [Full Text] [Related]

  • 12. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep 19; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 13. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
    Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh DA, El Abkari M, Martin PM, Ouafik L.
    Int J Biol Markers; 2010 Sep 19; 25(4):179-84. PubMed ID: 21161938
    [Abstract] [Full Text] [Related]

  • 14. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ, Kim JW, Jung JP, Cho JW, Nam ES, Cho SJ, Kim JS, Park HR, Min SK, Seo J, Min KW, Kim DH, Jeon JY.
    Hum Pathol; 2016 Apr 19; 50():90-100. PubMed ID: 26997442
    [Abstract] [Full Text] [Related]

  • 15. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X, Wang Y, Gao N, Wang J.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 19; 43(2):77-82. PubMed ID: 24742565
    [Abstract] [Full Text] [Related]

  • 16. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
    Fish JE, Flores Suarez CP, Boudreau E, Herman AM, Gutierrez MC, Gustafson D, DiStefano PV, Cui M, Chen Z, De Ruiz KB, Schexnayder TS, Ward CS, Radovanovic I, Wythe JD.
    Circ Res; 2020 Aug 28; 127(6):727-743. PubMed ID: 32552404
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M, Kafatos G, Taylor A, Gastanaga VM, Oliner KS, Hechmati G, Terwey JH, van Krieken JH.
    Eur J Cancer; 2015 Sep 28; 51(13):1704-13. PubMed ID: 26049686
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
    Uvirova M, Simova J, Kubova B, Dvorackova N, Tomaskova H, Sedivcova M, Dite P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep 28; 159(3):466-71. PubMed ID: 26077004
    [Abstract] [Full Text] [Related]

  • 19. Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.
    Bhaumik S, Ahmad F, Das BR.
    Med Oncol; 2016 Oct 28; 33(10):117. PubMed ID: 27637917
    [Abstract] [Full Text] [Related]

  • 20. Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits.
    Ma W, Brodie S, Agersborg S, Funari VA, Albitar M.
    Mol Diagn Ther; 2017 Oct 28; 21(5):571-579. PubMed ID: 28639239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.